SMS Lifesciences India Ltd - 540679 - Unaudited Financial Results [Q1F22]
We would like to inform you that the Board of Directors of the Company at their Meeting held on August 13, 2021, have inter-alia considered and approved the un-audited [Standalone and Consolidated] financial results for the quarter ended June 30, 2021, as recommended by the Audit Committee. SMS Lifesciences India Ltd - 540679 - Board Meeting Outcome for OUTCOME OF THE BOARD MEETING
we would like to inform you that the Board of Directors of the Company at their Meeting held on August 13, 2021, have inter-alia considered and approved the un-audited [Standalone and Consolidated] financial results for the quarter ended June 30, 2021, as recommended by the Audit Committee. SMS Lifesciences India Ltd - 540679 - Board Meeting Intimation for Considering Financial Results Of Quarter Ended June 30, 2021.
SMS Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2021 ,inter alia, to consider and approve i) Unaudited financial results (Standalone a nd Consolidated) of the Company for the first quarter ended June 30, 2021 . ii) The request received from Promoter/Promoter Group regarding reclassification to Public category pursuant to Regulation 31 (A) of SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015. iii) any other items as may be decided by the Board of Directors. SMS Lifesciences India Ltd - 540679 - Reclassification Of Promoters (Request Received)
Enclosed herewith is disclosure pursuant to Regulation 31A(8)(a) of SEBI (Listing Obligations & Disclosure Requirements) Regulations. 2015. SMS Lifesciences India Ltd - 540679 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2021. SMS Lifesciences India Ltd - 540679 - Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Trupti Ranjan MohantyDesignation :- Company Secretary and Compliance Officer SMS Lifesciences India Ltd - 540679 - Consolidated Related Party Transactions [H2-F21]
Disclosure as per Reg. 23 (9) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 SMS Lifesciences India Ltd - 540679 - Shareholding for the Period Ended June 30, 2021
SMS Lifesciences India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click here SMS Lifesciences India Ltd - 540679 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Murali Krishna Satya Srinivasu Tamminedi SMS Lifesciences India Ltd - 540679 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pixalot Labs Pvt Ltd & Suresh Babu Potluri